Artiva Biotherapeutics (NASDAQ:ARTV – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.63) earnings per share for the quarter, hitting the consensus estimate of ($0.63), FiscalAI reports. Artiva Biotherapeutics Stock Performance Shares of ARTV traded down $0.31 on Friday, reaching $11.27. The stock had a trading volume of 214,660 shares, […]

Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) posted its earnings results on Thursday. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.01, FiscalAI reports. The firm had revenue of $1.63 million during the quarter, compared to analyst estimates of $1.38 million. Aclaris Therapeutics had […]

Odyssey Therapeutics (NASDAQ:ODTX – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($1.74) earnings per share for the quarter, FiscalAI reports. Odyssey Therapeutics Stock Performance ODTX traded up $0.66 during trading on Thursday, reaching $21.55. 123,152 shares of the stock were exchanged, compared to its average volume of 254,668. The […]

Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.01), FiscalAI reports. Aldeyra Therapeutics Stock Down 0.6% ALDX traded down $0.01 during midday trading on Thursday, hitting $1.59. 573,829 shares of the […]

Entrada Therapeutics (NASDAQ:TRDA – Get Free Report) issued its earnings results on Wednesday. The company reported ($1.01) earnings per share for the quarter, topping the consensus estimate of ($1.05) by $0.04, FiscalAI reports. The business had revenue of $0.90 million for the quarter, compared to analyst estimates of $2.23 million. Entrada Therapeutics had a negative […]

Context Therapeutics (NASDAQ:CNTX – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05), FiscalAI reports. Context Therapeutics Stock Up 11.5% CNTX traded up $0.07 during trading on Wednesday, hitting $0.69. The company’s stock had a […]

Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) released its earnings results on Wednesday. The company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.12), FiscalAI reports. The business had revenue of $1.11 million for the quarter, compared to the consensus estimate of $10.00 million. Tenaya Therapeutics Price […]

Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.14, FiscalAI reports. The company had revenue of $39.66 million for the quarter, compared to the consensus estimate of $33.88 million. Zevra Therapeutics […]

Cyclerion Therapeutics (NASDAQ:CYCN – Get Free Report) announced its earnings results on Tuesday. The company reported ($0.41) earnings per share for the quarter, topping analysts’ consensus estimates of ($7.10) by $6.69, FiscalAI reports. Cyclerion Therapeutics had a negative net margin of 170.11% and a negative return on equity of 62.10%. Cyclerion Therapeutics Stock Up 0.9% […]

Travere Therapeutics (NASDAQ:TVTX – Get Free Report) released its earnings results on Tuesday. The company reported ($0.37) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.24), Zacks reports. Travere Therapeutics had a negative return on equity of 26.16% and a negative net margin of 4.00%. Travere Therapeutics Stock Performance […]